Jia Ruan, MD, PhD¹, Melissa C. Larson, MS^2*, Zhengming Chen, PhD, MPH^1*, N. Nora Nora Bennani, MD³, Pamela B. Allen, MD⁴, David L. Jaye, MD⁵, Jonathon B. Cohen, MD, MS⁶, Dai Chihara, MD⁷, Francisco Vega, MD, PhD⁸, Giorgio Inghirami, MD^9*, Eric Mou, MD¹⁰, Carla Casulo, MD¹¹, Neha Mehta-Shah, MD, MSCI¹², Peter Martin, FRCPC, MD, MS¹³, Matthew J. Maurer, DSc², Brad S. Kahl, MD¹², Izidore S. Lossos, MD¹⁴, Christopher R. Flowers, MD⁷, James R. Cerhan, MD, PhD² and Andrew L. Feldman, MD¹⁵

¹Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY
²Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Winship Cancer Institute, Emory University, Atlanta, GA
⁵Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Dunwoody, GA
⁶Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
⁷Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁸Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY
¹⁰Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
¹¹University of Rochester Medical Center, Rochester, NY
¹²Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
¹³Meyer Cancer Center, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY
¹⁴Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
¹⁵Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Robert Stuver, MD¹, Harleigh Haynie, BS^2*, Zachary D. Epstein-Peterson, MD¹, William T. Johnson, DO¹, Niloufer Khan, MD¹, Anita Mazloom, MD³, Alison J. Moskowitz, MD¹, Esther Drill, DrPH^2* and Steven M. Horwitz, MD¹

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
³University of South Alabama, Mobile

Robert Stuver, MD¹, Zachary D. Epstein-Peterson, MD¹, William T. Johnson, DO¹, Niloufer Khan, MD¹, Craig S. Sauter, MD^2*, Michael Scordo, MD³, Gunjan L. Shah, MD^4*, Alison J. Moskowitz, MD¹ and Steven M. Horwitz, MD¹

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland Clinic, Cleveland, OH
³Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center/New York, New York, NY
⁴Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY

Alex F. Herrera, MD¹, Stephen M. Ansell, MD, PhD², Pier Luigi Zinzani, MD, PhD³, John Radford, MD, FRCPath, FMedSci^4*, Kami J. Maddocks, MD⁵, Antonio Pinto, MD^6*, Graham P. Collins, MBBS, MA, MRCP, FRCPath, DPhil⁷, Veronika Bachanova, MD, PhD⁸, Nancy L. Bartlett, MD⁹, Isabelle Bence-Bruckler, MD^10*, Mehdi Hamadani, MD¹¹, Justin Kline, MD¹², Jiri Mayer, MD, PhD^13*, Kerry J. Savage, MD, MSc, FRCPC¹⁴, Ranjana H. Advani, MD¹⁵, Paolo F. Caimi, MD¹⁶, René-Olivier Casasnovas, MD, PhD^17*, Tatyana A. Feldman, MD¹⁸, Brian T. Hess, MD¹⁹, Mariana Bastos-Oreiro, MD, PhD^20*, Sunil Iyengar, MRCP, FRCPath, PhD^21*, Árpád Szomor, MD, PhD^22*, William Townsend^23*, Marc Andre, MD^24*, Jerzy Dyczkowski, PhD^25*, Sandy Eisen, MB BChir^26*, Andrzej Urban, MD, PhD^25*, Serafino Pantano, PhD^25*, Hans G. Cruz, PhD²⁵, Luqiang Wang, PhD^27*, Yanina Negievich, MD^25*, Jens Wuerthner, MD, PhD²⁵ and Carmelo Carlo-Stella, MD, PhD²⁸

¹Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA
²Division of Hematology, Mayo Clinic, Rochester, MN
³Institute of Hematology “Seràgnoli”, University of Bologna, Bologna, Italy
⁴Manchester Academic Health Science Centre, NIHR Clinical Research Facility, the Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom
⁵Division of Hematology, Department of Internal Medicine, The James Cancer Hospital at The Ohio State University, Columbus, OH
⁶Hématology-Oncology and Stem-Cell Transplantation Unit, Department of Hematology, National Cancer Institute, Fondazione 'G. Pascale,' IRCCS, Naples, Italy
⁷Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, ENG, United Kingdom
⁸Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
⁹Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
¹⁰The Ottawa Hospital, Ottawa, ON, Canada
¹¹Division of Hematology & Oncology, BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI
¹²Department of Medicine Section of Hematology/Oncology, University of Chicago Medicine, Chicago, IL
¹³Hematology and Oncology, University Hospital Brno, Czech Republic, Brno, Czech Republic
¹⁴Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada
¹⁵Stanford Cancer Institute, Stanford University, Stanford, CA
¹⁶Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
¹⁷Hématologie Clinique, CHU Dijon Bourgogne, Dijon, France
¹⁸Hackensack Meridian Health, Hackensack, NJ
¹⁹Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
²⁰Servicio de Hematología y Hemoterapia, Hospital Gral. Univ. Gregorio Marañón, Madrid, Madrid, Spain
²¹The Royal Marsden, London, United Kingdom
²²First Department of Internal Medicine, University of Pécs, Pécs, Hungary
²³National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust and UCLH, London, United Kingdom
²⁴Department of Haematology, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium
²⁵ADC Therapeutics SA, Épalinges, Switzerland
²⁶CNS Consult Ltd, London, United Kingdom
²⁷ADC Therapeutics America, Inc., Murray Hill, NJ
²⁸Department of Oncology and Hematology, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy

Wendy Cozen, DO, MPH¹, Jia Yin Wan, M.S.^2*, David V Conti, PhD^3*, Marta Epeldegui, PhD^4*, Yu Guo, PhD^5*, Larry Magpantay, M.S.^5*, Ilja Nolte, Ph.D.^6*, Arjan Diepstra, M.D., Ph.D.⁷, Lynn Levin, Ph.D., M.P.H.^8* and Otoniel Martinez-Maza, PhD^9*

¹Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA
²Department of Epidemiology and Biostatistics, University of California Irvine, Irvine, CA
³Center for Genetic Epidemiology, Department of Population and Public Health Science, University of Southern California, Los Angeles, CA
⁴AIDS Institute, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, CA
⁵AIDS Institute, University of California Los Angeles, David Geffen School of Medicine, Los Angeles, CA
⁶University Medical Center Groningen, Groningen, NLD
⁷Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
⁸Statistics and Epidemiology Branch, Walter Reed Army Institute of Research, Silver Spring, MD
⁹Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA

David Sibon, MD, PhD^1,2*, Laurence Lamant, MD, PhD^3*, Véronique Vergé, MD^4*, Loic Ysebaert, MD, PhD^5*, Catherine Thieblemont, MD, PhD⁶, Krimo Bouabdallah, MD^7*, Jehan Dupuis, MD^8*, Rémy Gressin, MD^9*, Emmanuel Bachy, MD, PhD^10*, Yann Guillermin, MD^11*, Nicolas Daguindau, MD^12*, Charlotte Syrykh, MD^3*, Choquet Sylvain, MD^13*, Pierre Feugier, MD, PhD^14*, Caroline Delette, MD^15*, Olivier Casasnovas, MD^16*, Marlene Ochmann, MD^17*, Ronan Le Calloch, MD^18*, Emmanuel Gyan, MD, PhD^19,20, Herve Tilly, MD, PhD²¹, Gandhi Laurent Damaj, MD, PhD²² and Olivier Tournilhac, MD, PhD^23*

¹Lymphoid Malignancies Department, Henri Mondor University Hospital, Creteil, France
²Faculty of Medicine and Health, Campus Henri Mondor, Paris-Est Creteil University, Creteil, France
³Pathology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
⁴Département de Biologie et Pathologie Médicales, Gustave Roussy/Université Paris-Saclay, Villejuif, France
⁵Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
⁶Hemato-oncology Department, Université de Paris Cité/Saint-Louis University Hospital/AP-HP, Paris, France
⁷Department of Hematology and Cell Therapy, Bordeaux University Hospital, Bordeaux, France
⁸Lymphoid Malignancies Department, Henri Mondor University Hospital, Créteil, France
⁹Department of clinical hematology, Centre Hospitalier et Universitaire de Grenoble-Alpes, Grenoble, France
¹⁰Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France
¹¹Hematology Department, Centre Léon Bérard, Lyon, France
¹²Hematology Department, CH Annecy Genevois, Metz-Tessy, France
¹³Department of Clinical Hematology, Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, Paris, France
¹⁴Hematology Department, University Hospital of Nancy, Vandoeuvre, France
¹⁵Service d’Hématologie Clinique et de Thérapie Cellulaire, CHU Amiens, Amiens, France
¹⁶Hematology Department, University Hospital F. Mitterrand and Inserm UMR 1231, Dijon, France
¹⁷Hematology Department, Hospital of Orleans, Orleans, France
¹⁸Hematology Department, General Hospital, Quimper, France
¹⁹Dept Hematology & Cell Therapy, University Hospital of Tours, Tours, France
²⁰Service D'Hematologie et Therapie Cellulaire, CHU de Tours, Tours Cedex, France
²¹Hematology Department, Centre Henri Becquerel, Rouen, France
²²Hematology Department, CHU de Caen Normandie, Caen, France
²³Hematology Department, CHU Estaing/Universite Clermont Auvergne, Clermont Ferrand, AURA, France

Sumit Gupta, MD, PhD^1,2,3, Nancy N Baxter, MD, PhD^4*, David C. Hodgson, MD, MPH, FRCPC^5*, Jason Pole, PhD^6*, Cindy Lau, MPH^7*, Rinku Sutradhar, PhD^8*, Paul Nathan, MD^1,3,9* and Angela Punnett, MD^2*

¹Cancer Research Program, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
²Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada
³Faculty of Medicine, University of Toronto, Toronto, ON, Canada
⁴University of Melbourne, Melbourne, Australia
⁵Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁶University of Queensland, Brisbane, AUS
⁷ICES, Toronto, ON, Canada
⁸Cancer Research Program, ICES, Toronto, ON, Canada
⁹Division of Haematology/Oncology, Hospital For Sick Children, Toronto, ON, Canada

Christopher A. Yasenchak, MD¹, Rodolfo Bordoni, MD^2*, Dipti Patel-Donnelly, MD³, Timothy Larson, MD^4*, Jerome Goldschmidt, MD^5*, Ralph V. Boccia, MD, FACP⁶, Vivian J.M. Cline, MD^7*, Adrija Mamidipalli, MBBS, MAS⁸, Jingmin Liu^8* and Joseph T. Beck, MD, FACP^9*

¹Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR
²Georgia Cancer Specialists, Marietta, GA
³Virginia Cancer Specialists, Fairfax, VA
⁴Minnesota Oncology P.A., Minneapolis, MN
⁵Oncology and Hematology Associates of SW Virginia, Blackburgs, VA
⁶The Center for Cancer and Blood Disorders, Bethesda, MD
⁷U.S. Oncology Associates, Austin, TX
⁸Seagen Inc., Bothell, WA
⁹Highlands Oncology Group, Fayetteville, AR

Ethan A. Burns, MD¹, Sunil Mathur, PhD^1*, Darshil Choksi, BS^2*, Hala Hassanain, MD^3*, Yuqi Zhang, MD^3*, Cesar Gentille Sanchez, MD⁴, Ryan B. Kieser, MD¹, Carrie Yuen, MD⁵, Shilpan S. Shah, MD¹, Siddhartha Ganguly, MD^6* and Sai Ravi Kiran Pingali, MD⁷

¹Houston Methodist Cancer Center, Houston, TX
²Texas A&M School of Medicine, Houston, TX
³Houston Methodist Hospital, Houston, TX
⁴Hematology and Medical Oncology, University of Arkansas for Medical Sciences, Little Rock, AR
⁵Malignant Hematology, Houston Methodist Cancer Center, Houston, TX
⁶Houston Methodist Hospital and Cancer Center, Houston, TX
⁷Houston Methodist Cancer Center, HOUSTON, TX

Cong Li, MD, Tao Lei, MD^*, Haifeng Yu, MD^*, Xi Chen^*, Shuiyun Han^*, Shuailing Peng^* and Haiyan Yang, PhD

Department of Lymphatic Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences（Zhejiang Cancer Hospital），Institute of Basic Medicine and Cancer（IBMC），Chinese Academy of Sciences, Hangzhou, China

Supriya Gupta, MD^1* and Philip A Haddad, MD²

¹Louisiana State University Health Sciences Centre, Shreveport, LA
²LSUHSC-S/Overton Brooks VAMC, Shreveport, LA

Richa Parikh, MD¹ and Arya Roy, MD^2*

¹Department of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI
²Roswell Park Comprehensive Cancer Center, Buffalo, NY

Yanan Zhu^1*, Wenjuan Yu, MD^2*, Jie Jin, M.D., Ph.D.³, Juying Wei^2*, Hongyan Tong, MD^2*, Chunmei Yang^2*, Xia Li, PhD^2* and Wanzhuo Xie^2*

¹Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
²Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
³Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

Anna Sureda¹, Antonio Pinto^2*, Herve Ghesquieres, MD, PhD^3*, Franck Morschhauser, MD, PhD^4*, Olivier Tournilhac, MD, PhD^5*, Pim Mutseaers, MD^6*, Josée M. Zijlstra, MD PhD⁷, Floris A. De Jong, PhD^8*, Tomas Janik^9* and Pier Luigi Zinzani, MD, PhD¹⁰

¹Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL); Biomedical Research Institute, Universitat de Barcelona, Barcelona, Spain
²Hematology-Oncology and Stem-Cell Transplantation Unit, Department of Hematology and Innovative Therapies, National Cancer Institute, Fondazione 'G. Pascale', IRCCS, 80131, Italy
³Department of Hematology, Lyon Sud University Hospital/Hospices Civils de Lyon, Pierre Benite, France
⁴HOPITAL CLAUDE HURIEZ, Lille, FRA
⁵Service d'Hématologie et de Thérapie Cellulaire, CHU Estaing, Université Clermont Auvergne, EA7453; CIC-1405, Clermont-Ferrand, France, Clermont-Ferrand, France
⁶Department of Hematology, Erasmus MC Cancer Center, Rotterdam, Netherlands
⁷Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands, Amsterdam, Netherlands
⁸Mundipharma Research Limited, Cambridge, UK, Cambridge, United Kingdom
⁹Mundipharma Research Limited, Cambridge, United Kingdom
¹⁰Institute of Hematology “Seràgnoli” University of Bologna, Bologna, Italy

Arya Mariam Roy, MBBS¹, Richa Parikh, MD², Muhammad Salman Faisal, MD, MBBS¹, Hassan Awada, MD³, Karan Jatwani, MD^1* and Paola Ghione^4*

¹Roswell Park Comprehensive Cancer Center, Buffalo, NY
²Department of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI
³Department of Hematology and Oncology, Roswell Park Comprehensive Cancer Center, Akron, OH
⁴Department of Hematology and Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Lauren Fahmy, BS¹, Hye Ryung Yang, MD^2*, Bradley Kwinta, BA^1*, Volkan Beylergil, MD^2*, Celine M Schreidah, BS^1*, Lawrence H. Schwartz, MD^3* and Larisa J Geskin, MD^4*

¹Columbia University Vagelos College of Physicians and Surgeons, New York, NY
²Department of Radiology, Columbia University Medical Center, New York, NY
³Columbia University College of Physicians and Surgeons, New York, NY
⁴Department of Dermatology, Columbia University Irving Medical Center, New York, NY

Luis Alberto de Padua Covas Lage, MD, PhD^1,2,3,4*, Pedro Paulo Faust Machado, MD^5*, Cadiele Oliana Reichert, MSc^6*, Eliana C M Cristina Martins Miranda, PhD, MEd^7,8,9*, Hebert Fabricio Culler, MSc, PhD^10,11*, Sheila Aparecida Coelho de Siqueira, MD, PhD^12,13*, Renata Oliveira Costa, MD, PhD¹⁴, Denis Miyashiro, MD^15*, Jose Sanches, MD PhD^16*, Vanderson Rocha, MD, PhD^17,18,19*, Carlos S. Chiattone, MD, PhD^20,21,22,23 and Juliana Pereira, MD, PhD^24,25,26

¹Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
²Medical Research Laboratory on Molecular Hematology (LIM-31), Universidade de São Paulo, São Paulo, Brazil
³Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
⁴Departament of Hematology, Hemotherapy and Cell Therapy, Hospital Das Clinicas Da Universidade De Sao Paulo, São Caetano do Sul, SP, Brazil
⁵Department of Hematology, Hemotherapy and Cell Therapy, University of São Paulo, São Paulo, Brazil
⁶Medical Laboratory Investigation 19 - LIM19, Universidade de São Paulo (USP), Sao Paulo, Brazil
⁷Grupo de Estudos de Molesticas OncoHematologicas - GEMOH, Campinas, Brazil
⁸Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil
⁹Hematology and Hemotherapy Center, University of Campinas, Campinas, SP, Brazil
¹⁰Department of Hematology, Hemotherapy and Cell Therapy, Universidade de São Paulo (USP), Sao Paulo, Brazil
¹¹Medical Laboratory Investigation 31 - LIM31, Universidade de São Paulo (USP), Sao Paulo, Brazil
¹²Department of Pathology, Universidade de São Paulo (USP), Sao Paulo, Brazil
¹³Division of Pathology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
¹⁴Department of Hematology and Hemotherapy, Centro Universitário Lusíadas, Santos, Brazil
¹⁵University of Sao Paulo, Sao Paulo, Brazil
¹⁶University of Sao Paulo Medical School, Sao Paulo, SP, BRA
¹⁷Service of Hematology, Transfusion and Cell Therapy, and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Hospital das Clinicas, Faculty of Medicine, Sao Paulo University (FM-USP), Sao Paulo, Brazil
¹⁸Institut de Recherche de Saint-Louis (IRSL) EA3518, Eurocord, Saint Louis Hospital, APHP, Université de Paris, Paris, France
¹⁹Serviço de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil
²⁰Hematology Division, Santa Casa Medical School of Sao Paulo, Sao Paulo, Brazil
²¹Oncology Nucleus, Samaritano Hospital - Higienopolis, Sao Paulo, Brazil
²²Department of Medicine, Santa Casa Medicine School, Sao Paulo, Brazil
²³SANTA CASA MEDICAL SCHOOL, sao paulo, Brazil
²⁴Department of Hematology- Hospital das Clínicas da Faculdade de Medicina da USP- HCFMUSP, Universidade de São Paulo, São Paulo, Brazil
²⁵Department of Hematology, Hospital Alemão Oswaldo Cruz, São Pailo, Brazil
²⁶Serviço de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SAO PAULO, Brazil

William T. Johnson, DO^1,2, Zachary D. Epstein-Peterson, MD^1,2, Nivetha Ganesan, MPH^1*, Tiffany Chang^1*, Natasha Galasso, MSW^1*, Robert Stuver, MD¹, Niloufer Khan, MD^1,2*, Gilles Salles, MD, PhD^1,2, Alison J. Moskowitz, MD^1,2, Santosha Vardhana, MD, PhD^1,3 and Steven M. Horwitz, MD²

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Medicine, Weill Cornell Medical College, New York, NY
³Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY

Carolina C P Feres, MD^1*, Larissa LC Teixeira^2*, Leonardo Javier Arcuri³, Gabriela Amaral Vieira^4*, Carolina Leme de Moura Pereira^4*, Nelson Hamerschlak, MD, PhD⁵ and Guilherme Fleury Perini, MD⁶

¹Hematologia, Hospital Israelita Albert Einstein, São Paulo, Brazil
²Hospital Israelita Albert Einstein, Sao Paulo, Brazil
³Hospital Albert Einstein / HSCT Program, Hospital Albert Einstein, Sao Paulo, Brazil
⁴Hospital Israelita Albert Einstein, São Paulo, Brazil
⁵Hospital Israelita Albert Einstein, Sao Paolo, Brazil
⁶Hospital Israelita Albert Einstein, São Paulo, AC, Brazil

So Heun Lee^1*, Hyungwoo Cho^1*, Jin Sook Ryu^2*, Chan-Sik Park^3*, Sang-wook Lee^4*, Yoon Sei Lee^5*, Yoon Seok Choi, MD, PhD⁶ and Dok Hyun Yoon, MD, PhD^1*

¹Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
²Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
³Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁴Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁵Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁶Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea, Republic of (South)

Marcie Haydon, Ph.D.^1*, Amie E. Hwang, PhD, MPH², Esther Lam, M.P.H.^3*, Laura Buchanan, R.N.^4*, Marta Epeldegui, PhD^5*, Joel Milam, Ph.D.^6*, Thomas M. Mack, M.D., M.P.H.^4*, David V Conti, PhD^7*, John Hopper, Ph.D.^8* and Wendy Cozen, DO, MPH⁹

¹UCI, Department of Medicine, Orange, CA
²Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA
³University of California Irvine, Orange, CA
⁴University of Southern California, Keck School of Medicine of USC, Los Angeles, CA
⁵AIDS Institute, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, CA
⁶Department of Epidemiology and Biostatistics, University of California Irvine, Irvine, CA
⁷Center for Genetic Epidemiology, Department of Population and Public Health Science, University of Southern California, Los Angeles, CA
⁸The University of Melbourne, Melbourne, AUS
⁹Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Manhattan Beach, CA

Henry S. Ngu^1*, Diego Villa, MD¹, Alina S. Gerrie, MD, MPH, FRCPC¹, Christopher P. Venner, MD, FRCPC¹, Andrew Lytle, MD, PhD^2*, Brian Skinnider, MD, FRCPC^2*, Jeffrey W. Craig, MD, PhD^2*, Graham W. Slack, MD², David W. Scott, PhD, MD, FRACP, FRCPA¹, Laurie H. Sehn, MD, MPH¹ and Kerry J. Savage, MD, MSc, FRCPC¹

¹Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
²Centre for Lymphoid Cancer, Department of Pathology, BC Cancer, Vancouver, BC, Canada

Jun Ma^1*, Yuqin Song, MD², Yan Xie^2*, Hui-Lai Zhang^3*, Yuerong Shuang^4*, Zhigang Peng^5*, Li Fei⁶, Yunhong Huang^7*, Weili Zhao^8*, Wenrong Huang^9*, Yali Pan^10*, Mingying Liu^10*, Feiwu Ran^10*, Hui Feng^10,11*, Sheng Yao^10,11*, Patricia Keegan^11*, Jianjun Zou^10* and Jun Zhu, PhD¹²

¹Harbin Institute of Hematology and Oncology, Harbin, China
²Peking University Cancer Hospital & Institute, Beijing, China
³Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⁴Jiangxi Cancer Hospital, Nanchang, China
⁵First Affiliated Hospital of Guangxi Medical University, NANING, China
⁶The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China
⁷The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China
⁸Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁹The Fifth Medical Center of the General Hospital of the Chinese people's Liberation Army, Beijing, China
¹⁰Shanghai Junshi Biosciences, Shanghai, China
¹¹TopAlliance Biosciences, Rockville
¹²Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China

Shigeru Kusumoto, MD, PhD¹, Wataru Munakata, MD, PhD^2*, Ryunosuke Machida, Master of Engineering^3*, Takashi Terauchi, MD, PhD^4*, Hiroaki Onaya, MD, PhD^5*, Masahiko Oguchi, MD, PhD^6*, Shinsuke Iida, MD, PhD¹, Kisato Nosaka, MD, PhD⁷, Yasuhiro Suzuki, MD, PhD^8*, Yasuhiko Harada, MD, PhD^9*, Kana Miyazaki, MD, PhD¹⁰, Masaki Maruta, MD, PhD^11*, Noriko Fukuhara, MD, PhD¹², Tomomi Toubai, MD, PhD¹³, Nobuko Kubota, MD, PhD^14*, Ken Ohmachi, MD^15*, Kazuhito Yamamoto, MD, PhD¹⁶, Takahiro Kumode, MD, PhD^17*, Ishikazu Mizuno, MD^18*, Takayuki Tabayashi, MD, PhD^19*, Hideki Tsujimura, MD, PhD²⁰, Nobuyuki Takayama, MD, PhD²¹, Kohsuke Asagoe, MD, PhD^22*, Isao Yoshida, MD, PhD^23*, Yasushi Takamatsu, MD, PhD^24*, Suguru Fukuhara, MD^2*, Mai Takeuchi, MD, PhD^25*, Ukihide Tateishi, MD, PhD^26*, Dai Maruyama, MD, PhD²⁷, Kunihiro Tsukasaki, MD, PhD²⁸ and Hirokazu Nagai, MD, PhD⁸

¹Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan
²Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
³Japan Clinical Oncology Group Data Center, National Cancer Center Hospital, Tokyo, Japan
⁴Department of Nuclear Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
⁵Department of Diagnostic and Inverventional Radiology, Aichi Cancer Center Hospital, Nagoya, Japan
⁶Medical Informatics Department / Radiation Oncology Department, The Cancer Institute Hospital Japanese Foundation for Cancer Research, Tokyo, Japan
⁷Cancer Center, Kumamoto University Hospital, Kumamoto, Japan
⁸Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
⁹Department of Hematology, Toyota Kosei Hospital, Toyota, Japan
¹⁰Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
¹¹Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Hospital, Toon, Japan
¹²Department of Hematology, Tohoku University Hospital, Sendai, Japan
¹³Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan
¹⁴Department of Hematology, Saitama Cancer Center, Saitama, Japan
¹⁵School of Medicine, Division of Hematology and Oncology, Tokai University, Isehara, Japan
¹⁶Aichi Cancer Center, Nagoya, Japan
¹⁷Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka-sayama, Japan
¹⁸Department of Hematology, Hyogo Cancer Center, Akashi, Japan
¹⁹Department of Hemetology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan
²⁰Division of Hematology-Oncology, Chiba Cancer Center, Chiba, Japan
²¹Department of Hematology, Kyorin University School of Medicine, Mitaka-shi, Tokyo, Japan
²²Department of Hematology and Oncology, Shiga General Hospital, Moriyama, Japan
²³Department of Hematologic Oncology, National Hospital Organization Shikoku Cancer Center, Mastuyama, Japan
²⁴Fukuoka University, Fukuoka, Japan
²⁵Department of Pathology, Kurume University, Kurume, Japan
²⁶Department of Diagnostic Radiology, Tokyo Medical and Dental University, Tokyo, Japan
²⁷Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
²⁸Department of Hematology, International Medical Center, Saitama Medical University, Saitama, Japan

Alexandra Elias^1*, Rishab Prakash, BS^1*, Loretta J. Nastoupil, MD², Nathan H. Fowler, MD³, Sairah Ahmed, MD¹, Ranjit Nair, MD², Luis Enrique Malpica Castillo, MD¹, Bouthaina S. Dabaja, MD^4*, Jie Xu, MD^5*, Jeffrey Medeiros, MD, PhD^5*, John Stewart, MD^1*, Wei Wang, PhD^6*, Chelsea C. Pinnix, MD, PhD⁴, Kelly Hunt, MD^7*, Mark W Clemens, MD^8*, Roberto N. Miranda, MD^5* and Swaminathan P. Iyer, MD²

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³The University of Texas, MD Anderson Cancer Center, Houston, TX
⁴Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Lymphoma & Myeloma, MD Anderson Cancer Center, The University of Texas, Houston, TX
⁷The University of Texas at MD Anderson Cancer Center, Houston, TX
⁸Department of Plastic Surgery, MD Anderson Cancer Center, Houston, TX

Xiaofei Zhou^1*, Diane R Mould^2*, Anna R K Franklin^3*, Lia Gore³, Xiang Bai^1* and Neeraj Gupta^1*

¹Takeda Development Center Americas, Inc. (TDCA), Lexington, MA
²Projections Research, Inc., Phoenixville, PA
³Children's Hospital Colorado, Center for Cancer and Blood Disorders and University of Colorado School of Medicine, Aurora, CO

Michael J. LaRiviere, MD^1*, Tina Vaziri, BS^2*, Michael Farwell, MD^3*, Amit Maity, MD, PhD^4*, Ima Paydar, MD^1*, Stephen J. Schuster, MD⁵, Sunita Dwivedy Nasta, MD⁵, Elise A. Chong, MD⁵, Daniel J. Landsburg, MD⁵, John P. Plastaras, MD, PhD^1* and Jakub Svoboda, MD⁵

¹Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA
²George Washington University, Washington, DC
³Division of Nuclear Medicine and Clinical Molecular Imaging, University of Pennsylvania, Philadelphia, PA
⁴Department of Radiation Oncology, University of Utah, Salt Lake City, UT
⁵Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA